Pfizer Research Rides the Wave.
Pfizer's Research University (ePRU) at Sandwich in Kent has commissioned fast-growing BrightWave, the Hove-based e-Learning specialists, to develop an e-learning module for Pfizer's re-designed education programme on the development of medicines.
The BrightWave programme will form part of a modularized approach to education that will enable research teams, comprising pharmaceutical scientists, project managers, regulatory advisers and others, to participate more effectively in Exploratory Development, a key phase that can last up to three years.
Sue Ward, Pfizer Research University's senior adviser says that PRU is delighted to be using BrightWave's experience and approach to e-Learning development. "This is an ambitious new learning architecture for us which we are convinced will produce substantial rewards. BrightWave has the expertise and experience we need in an e-Learning partner and I'm excited that we are working together."
Pfizer Inc discovers, develops, manufactures and markets leading prescription medicines for humans and animals and many of the world's best-known consumer brands. In the UK, since 1990, Pfizer has invested over £1billion. The company employs more than 6000 people in the UK and is one of the top three suppliers of medicines to the NHS.
Notes to Editor: